Physical Activity and Health Research Group ('PaHerg'), Research Institute of Hospital '12 de Octubre' ('imas12'), Madrid, Spain; Department of Systems Biology, University of Alcalá, Madrid, Spain.
Department of Sport and Computer Science, Section of Physical Education and Sports, Faculty of Sport, Universidad Pablo de Olavide, Sevilla, Spain; EVOPRED Research Group, Universidad Europea de Canarias, Tenerife, Spain.
Clin Nutr. 2024 Mar;43(3):692-700. doi: 10.1016/j.clnu.2024.01.026. Epub 2024 Jan 26.
BACKGROUND & AIMS: Ketone supplementation is gaining popularity. Yet, its effects on exercise performance when muscle glycogen cannot be used remain to be determined. McArdle disease can provide insight into this question, as these patients are unable to obtain energy from muscle glycogen, presenting a severely impaired physical capacity. We therefore aimed to assess the effects of acute ketone supplementation in the absence of muscle glycogen utilization (McArdle disease).
In a randomized cross-over design, patients with an inherited block in muscle glycogen breakdown (i.e., McArdle disease, n = 8) and healthy controls (n = 7) underwent a submaximal (constant-load) test that was followed by a maximal ramp test, after the ingestion of a placebo or an exogenous ketone ester supplement (30 g of D-beta hydroxybutyrate/D 1,3 butanediol monoester). Patients were also assessed after carbohydrate (75 g) ingestion, which is currently considered best clinical practice in McArdle disease.
Ketone supplementation induced ketosis in all participants (blood [ketones] = 3.7 ± 0.9 mM) and modified some gas-exchange responses (notably increasing respiratory exchange ratio, especially in patients). Patients showed an impaired exercise capacity (-65 % peak power output (PPO) compared to controls, p < 0.001) and ketone supplementation resulted in a further impairment (-11.6 % vs. placebo, p = 0.001), with no effects in controls (p = 0.268). In patients, carbohydrate supplementation resulted in a higher PPO compared to ketones (+21.5 %, p = 0.001) and a similar response was observed vs. placebo (+12.6 %, p = 0.057).
In individuals who cannot utilize muscle glycogen but have a preserved ability to oxidize blood-borne glucose and fat (McArdle disease), acute ketone supplementation impairs exercise capacity, whereas carbohydrate ingestion exerts the opposite, beneficial effect.
酮类补充剂正日益流行。然而,当肌肉糖原无法被利用时,它对运动表现的影响仍有待确定。麦卡德尔病可以为这个问题提供一些见解,因为这些患者无法从肌肉糖原中获取能量,身体能力严重受损。因此,我们旨在评估在没有肌肉糖原利用的情况下(麦卡德尔病)急性酮补充的效果。
在一项随机交叉设计中,患有肌肉糖原分解遗传阻断的患者(即麦卡德尔病,n=8)和健康对照者(n=7)进行了亚最大(恒负荷)测试,之后进行了最大斜坡测试,在摄入安慰剂或外源性酮酯补充剂(30g D-β羟基丁酸/D1,3 丁二醇单酯)后。还在摄入碳水化合物(75g)后对患者进行了评估,这目前被认为是麦卡德尔病的最佳临床实践。
酮补充剂诱导所有参与者出现酮症(血液[酮] = 3.7±0.9mM)并改变了一些气体交换反应(特别是增加呼吸交换率,尤其是在患者中)。患者的运动能力受损(与对照组相比,峰值功率输出降低了 65%,p<0.001),酮补充进一步导致运动能力下降(与安慰剂相比降低了 11.6%,p=0.001),而对照组无影响(p=0.268)。在患者中,与酮相比,碳水化合物补充导致更高的峰值功率输出(增加 21.5%,p=0.001),与安慰剂相比也观察到类似的反应(增加 12.6%,p=0.057)。
在不能利用肌肉糖原但具有氧化血液中葡萄糖和脂肪能力的个体(麦卡德尔病)中,急性酮补充会损害运动能力,而摄入碳水化合物则会产生相反的有益作用。